本文選題：物理治療 + 肺癌��； 參考：《中國(guó)呼吸與危重監(jiān)護(hù)雜志》2017年04期

【摘要】：目的評(píng)估綜合物理治療對(duì)肺癌合并慢性阻塞性肺疾病(簡(jiǎn)稱慢阻肺)患者肺切除術(shù)或葉切除術(shù)后肺功能的影響。方法選取2005年1月至2014年5月因肺癌接受肺切除術(shù)或肺葉切除術(shù)的慢阻肺合并肺癌患者,根據(jù)術(shù)前是否接受物理治療分為綜合物理治療組(A組,55例)和未接受綜合物理治療組(B組,43例)。比較A組入院時(shí)(T1時(shí)間點(diǎn))和綜合物理治療后(T2時(shí)間點(diǎn))的肺功能的變化,同時(shí)比較A、B兩組患者手術(shù)后(T3時(shí)間點(diǎn))肺功能和臨床特征的變化。結(jié)果 A組患者進(jìn)行術(shù)前綜合物理治療后第1秒用力呼氣容積(FEV_1)、肺活量(VC)、50%肺活量位最大呼氣流速(FEF50)和25%肺活量位最大呼氣流速(FEF25)比基線值分別增加16.96%、14.75%、20.69%和13.79%,6分鐘步行距離得到顯著改善。術(shù)后FEV_1和VC顯著降低,小氣道功能和臨床特征顯著惡化,在Δ[T2-T1]階段,不同程度FEV_1%pred患者間肺功能變化差異無(wú)統(tǒng)計(jì)學(xué)意義;在Δ[T2-T3]階段,FEV_1%pred≥80%患者和50%≤FEV_1%pred80%患者FEF50和FEF25變化程度大于FEV_1%pred50%的患者。肺葉切除術(shù)患者肺功能B組患者低于A組患者(FEV_1:10.24%vs.22.44%;VC:10.13%vs.20.87%);在肺切除術(shù)患者中也存在相似的差異,但差異較小(FEV_1:36.33%vs.36.78%;VC:37.23%vs.38.98%)。結(jié)論綜合物理治療對(duì)于改善肺癌合并慢阻肺患者肺切除術(shù)或葉切除術(shù)后肺功能有重要意義。
[Abstract]:Objective to evaluate the effects of comprehensive physical therapy on pulmonary function in patients with lung cancer complicated with chronic obstructive pulmonary disease (COPD) after pneumonectomy or lobectomy. Methods from January 2005 to May 2014, patients with COPD complicated with lung cancer underwent pneumonectomy or lobectomy. According to whether the patients received physical therapy before operation, they were divided into two groups: group A (55 cases) and group B (43 cases). To compare the changes of pulmonary function between group A and group A (T 1) and T 2 after comprehensive physical therapy, and to compare the changes of lung function and clinical features between group A and group A (P < 0.05). Results in group A, forced expiratory volume (FEV 1), maximal expiratory flow rate (VEF 50%) and maximal expiratory flow rate (FEF25) in 25% vital capacity position were increased by 16.96 ~ 14.75% and 13.79 ~ 6 minutes, respectively, compared with baseline values. The distance between rows has been improved significantly. FEV1 and VC decreased significantly and the small airway function and clinical features deteriorated significantly after operation. There was no significant difference in pulmonary function between patients with FEV _ 1pred at 螖 [T2-T1] stage. In the stage of 螖 [T2-T3], FEV1Pred 鈮，

本文編號(hào)：2007714